Request Deal Involvement

Centurium Capital-backed CBPO Holdings completed the acquisition of China Biologic Products Holdings for $4.76bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Davis Polk & Wardwell

legal advisors

Davis Polk & Wardwell

Duff & Phelps

financial advisors

Duff & Phelps

Maples Group

legal advisors

Maples Group

Foote Group

pr advisors

Foote Group

Wilson Sonsini Goodrich & Rosati

legal advisors

Wilson Sonsini Goodrich & Rosati

Harney Westwood & Riegels

legal advisors

Harney Westwood & Riegels

Kirkland & Ellis

legal advisors

Kirkland & Ellis

Fangda Partners

legal advisors

Fangda Partners

Weil Gotshal and Manges

legal advisors

Weil Gotshal and Manges

Linklaters

legal advisors to debt providers

Linklaters

Ping An Bank

debt providers

Ping An Bank

Shanghai Pudong Development Bank

debt providers

Shanghai Pudong Development Bank

or

Principals

TRUSTAR CAPITAL (EX CITIC CAPITAL PARTNERS)

bidder

TRUSTAR CAPITAL (EX CITIC CAPITAL PARTNERS)

PARFIELD INTERNATIONAL

bidder

PARFIELD INTERNATIONAL

HILLHOUSE CAPITAL GROUP

bidder

HILLHOUSE CAPITAL GROUP

TAIBANG BIOLOGIC GROUP (EX CHINA BIOLOGIC PRODUCTS HOLDINGS INC)

target

TAIBANG BIOLOGIC GROUP (EX CHINA BIOLOGIC PRODUCTS HOLDINGS INC)

CBPO HOLDINGS LIMITED

bidder

CBPO HOLDINGS LIMITED

CENTURIUM CAPITAL

bidder

CENTURIUM CAPITAL

V-SCIENCES INVESTMENTS

bidder

V-SCIENCES INVESTMENTS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Centurium Capital-backed CBPO Holdings completed the acquisition of China Biologic Products Holdings for $4.76bn.